BackCatabasis Pharmaceuticals Overview

Catabasis Pharmaceuticals Accounts Payable

Latest accounts payable for CATB: $1.1M.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$1.14M

Peer average

Loading

Catabasis Pharmaceuticals Accounts Payable History

Loading

Catabasis Pharmaceuticals vs. peers: Accounts Payable Comparison

Loading

Catabasis Pharmaceuticals Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Catabasis Pharmaceuticals (CATB) FAQ

As of the most recent data (September 2025), CATB shows a accounts payable of $1.1M. Scroll down for historical charts and peer comparison views.

Tracking CATB's accounts payable over time shows whether Catabasis Pharmaceuticals is scaling, shrinking, or reshaping that part of the business. The current reading is $1.1M Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this accounts payable page, Stockcircle has Catabasis Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect accounts payable (currently $1.1M) with ownership activity and broader fundamentals.

Catabasis Pharmaceuticals's accounts payable is $1.1M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.